Dexamethasone attenuates inflammatory-mediated suppression of β2-adrenoceptor expression in rat primary mixed glia

J Neuroimmunol. 2020 Jan 15:338:577082. doi: 10.1016/j.jneuroim.2019.577082. Epub 2019 Nov 2.

Abstract

β2-adrenoceptors are G-protein coupled receptors expressed on both astrocytes and microglia that play a key role in mediating the anti-inflammatory actions of noradrenaline in the CNS. Here the effect of an inflammatory stimulus (LPS + IFN-γ) was examined on glial β2-adrenoceptor expression and function. Exposure of glia to LPS + IFN-γ decreased β2-adrenoceptor mRNA and agonist-stimulated production of the intracellular second messenger cAMP. Pre-treatment with the synthetic glucocorticoid and potent anti-inflammatory agent dexamethasone prevented the LPS + IFN-γ-induced suppression of β2-adrenoceptor mRNA expression. These results raise the possibility that inflammation-mediated β2-adrenoceptor downregulation in glia may dampen the innate anti-inflammatory properties of noradrenaline in the CNS.

Keywords: Astrocyte; Microglia; Multiple sclerosis; Neuroinflammation; Noradrenaline; β(2)-adrenoceptor.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Cells, Cultured
  • Cyclic AMP / biosynthesis
  • Dexamethasone / pharmacology*
  • Inflammation / metabolism*
  • Interferon-beta / pharmacology
  • Interferon-gamma / pharmacology
  • Lipopolysaccharides / pharmacology
  • Neuroglia / drug effects*
  • Neuroglia / metabolism
  • Rats
  • Rats, Wistar
  • Receptors, Adrenergic, beta-2 / drug effects*
  • Receptors, Adrenergic, beta-2 / genetics
  • Receptors, Adrenergic, beta-2 / physiology
  • Tumor Necrosis Factor-alpha / biosynthesis

Substances

  • Lipopolysaccharides
  • Receptors, Adrenergic, beta-2
  • Tumor Necrosis Factor-alpha
  • Interferon-beta
  • Dexamethasone
  • Interferon-gamma
  • Cyclic AMP